about
Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin ResistanceSerum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart FailureAngiopoietin-Like Proteins: A Comprehensive LookAssociation of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetesEffects of LDL Receptor Modulation on Lymphatic FunctionLack of angiopoietin-like-2 expression limits the metabolic stress induced by a high-fat diet and maintains endothelial function in miceAngiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration.Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients.Exercise Lowers Plasma Angiopoietin-Like 2 in Men with Post-Acute Coronary SyndromeAngiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytesAngiogenesis in the atherosclerotic plaque.ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.Cloning, expression and purification of functionally active human angiopoietin-like protein 2High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation.Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice.Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes
P2860
Q27303704-C74320D8-1BA3-4A39-AFE0-86284025C7FEQ28548351-97C86C57-9F90-40D1-A1EB-4545DBCB0D6CQ29395294-398B7DF1-2389-461F-B575-2DC60708D60FQ30641972-AF76F140-9CC7-46CC-A522-FACB90A4ED42Q34530204-072BD6CD-877C-4612-8D74-BF99C0EAF2A8Q35026349-11B584AD-37E6-4518-8F48-BBD39EE7FFB2Q35912788-6393B136-0A10-4023-91A5-9AC047245080Q35996260-F026B3AA-4D6B-4BE6-92C8-4D21C2773A17Q36162807-82529911-6144-4446-AF5C-0AE975DCE290Q37190893-B91D06CB-770B-4513-BE6F-86F38ED55980Q37645436-35885E7C-2055-4597-B58F-9DA29650026AQ40635839-AB93759E-4680-41C4-AE42-6E9E1CE3C4E9Q42750746-717098AF-CCA9-4A9D-953C-8923DE771E32Q43375847-A7DD960D-DC03-4942-9414-5FF92D9524E3Q46796252-A4FA0534-6249-4343-B293-220D1424CA91Q47699400-56BE4E2E-A5BF-4ECD-BB06-87CC72C076FFQ58692487-CB6805F5-BD71-4599-9D76-61636D949F10
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Angiopoietin-like 2 promotes atherogenesis in mice.
@en
type
label
Angiopoietin-like 2 promotes atherogenesis in mice.
@en
prefLabel
Angiopoietin-like 2 promotes atherogenesis in mice.
@en
P2093
P2860
P356
P1476
Angiopoietin-like 2 promotes atherogenesis in mice
@en
P2093
Anil Nigam
Cécile Martel
Louis Villeneuve
Martin Juneau
Mathieu Gayda
Maya Mamarbachi
Nada Farhat
Natacha Duquette
Nathalie Thorin-Trescases
P2860
P304
P356
10.1161/JAHA.113.000201
P577
2013-05-10T00:00:00Z